Product Information
ROPINIROLE HCL 4 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.0804 per EA under NDC 69452036120. Its NADAC has been published 164 times since May 10, 2023.
Strength
4 mg/1
Manufacturer
Bionpharma Inc.NDC
69452036120
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079229On Market Since
9/15/2022
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 4 MG TABLET has been published 164 times since May 10, 2023, and over the history we have for it it has declined 6.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0804 per EA |
|---|---|
| All-time high | $0.0962 (Jan 10, 2024) |
| All-time low | $0.0681 (Nov 20, 2024) |
| 52-week high | $0.0852 |
| 52-week low | $0.0771 |
| Median price | $0.0816 |
| Average price | $0.0811 |
| Largest weekly change | -23.6% (Apr 17, 2024) |
| Weeks tracked | 164 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 4 MG TABLET, manufactured by Bionpharma Inc., is $0.0804 per EA (NDC 69452036120), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 4 MG TABLET has declined 6.5%. It has been tracked across 164 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 4 MG TABLET?
Since May 10, 2023, the NADAC for ROPINIROLE HCL 4 MG TABLET has ranged from a low of $0.0681 (Nov 20, 2024) to a high of $0.0962 (Jan 10, 2024), with a median of $0.0816 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 4 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ROPINIROLE HCL 4 MG TABLET, but none are currently priced below it.
Who manufactures ROPINIROLE HCL 4 MG TABLET?
ROPINIROLE HCL 4 MG TABLET (NDC 69452036120) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification